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S U M M A R Y
Wepresent the ﬁrst case of human spondylodiscitis due to Shewanella algae. Our patient did not have any
predisposing factors. The portal of entrywas probably a cutaneous lesion on the leg, exposed to seawater.
Bacteria were isolated in pure culture from a needle biopsy specimen of the vertebral disk. Automated
identiﬁcation systems identiﬁed the organism as Shewanella putrefaciens. However, molecular biology
identiﬁed it as S. algae. Treatment with ceftriaxone and amikacin, then ciproﬂoxacin successfully
addressed the infection. We also review four published cases of human osteoarticular infections caused
by Shewanella spp: two cases of arthritis and two cases of osteomyelitis. Two patients had predisposing
factors, and contact with water was found in two cases. The clinical, radiological and biological
characteristics of S. algae spondylodiscitis are indistinguishable from those of spondylodiscitis of other
causes. A cutaneous lesion with exposure to water is a potential portal of entry. Molecular typing is
necessary to obtain a precise bacteriological identiﬁcation.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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The bacterium Shewanella spp, ﬁrst isolated in 1931 from
putreﬁed butter, was originally classiﬁed as Achromobacter
putrefaciens.1 In 1941 it was reclassiﬁed under the name of
Pseudomonas putrefaciens on the basis of morphology.2 The ﬁrst
human isolate was described in 1964.3 In 1972 it was reclassiﬁed
as Alteromonas putrefaciens on the basis of its G+C content.4 In 1985
it was yet again reclassiﬁed in a new genus Shewanella on the basis
of comparative 5S rRNA sequences, the type species being
Shewanella putrefaciens.5 Shewanella alga was recognized as a
new species in 19926 and renamed Shewanella algae in 1997.7More
than 30 species of Shewanella have been described but the only
Shewanella spp that have been recovered from human infections
are S. putrefaciens and S. algae. Shewanella sp is a saprophyte widely
distributed in nature worldwide. It is mainly found in marine
environments, but it can also be isolated from all kinds of water
reservoirs (lakes, rivers, open wells, sewage), soil, oil emulsions,
ﬁsh, beef, poultry, and dairy products.
We report here the ﬁrst case of spondylodiscitis caused by S.
algae in the human. Our patient did not have any predisposing
factors. The portal of entry was probably a cutaneous lesion on the
leg, exposed to seawater. The bacterium was isolated in pure
culture from a needle biopsy specimen of the vertebral disk.
Automated identiﬁcation systems misidentiﬁed the pathogen as S.* Corresponding author. Tel.: +33 3 22 66 84 30; fax: +33 3 22 66 84 98.
E-mail address: canarelli.brigitte@chu-amiens.fr (B. Canarelli).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2009.11.007putrefaciens. It was identiﬁed as S. algae by 16S rRNA sequence
analysis.
We performed a PubMed search for reports on Shewanella spp
osteoarticular infections and we summarize the four cases
reported so far.
2. Case report
A 58-year-old man was admitted to the University Afﬁliated
Hospital of Amiens, France, in August 2007 with severe back pain
aftermoving his furniture twodays earlier. Hismedical historywas
characterized by obesity, hypertension, and gout. On admission he
had a body temperature of 38.2 8C. Medical examination revealed
spinal stiffness and a 4  2 cm cutaneous–subcutaneous lesion on
the left leg with exudative discharge and cellulitis. Three weeks
earlier, the patient had injured his leg on ametal bar. He thenwent
ﬁshing (water level above the knee) in the Channel at Equien,
France. As his cutaneous lesion was not healing he was treated for
six days with oral pristinamycin (1 g twice daily) by his general
practitioner. Further examinations, including a neurological
examination, showed no other abnormalities. There was no
peripheral adenopathy. Biological investigations showed a serum
level of C-reactive protein (CRP) of 205 mg/l (normal <5 mg/l) and
an erythrocyte sedimentation rate (ESR) of 67 mm/h (normal
<10 mm/h). A blood leukocyte count and blood chemistry were
normal. A lumbar computed tomography (CT) scan showed only
degenerative disk disease. Echocardiography was normal. Three
sets of blood cultures (BacT/Alert, BioMe´rieux, Marcy l’Etoile,
France) were collected and remained sterile after ﬁve days.ses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Sagittal magnetic resonance images of the lumbar spine. (a) T1-weighted image demonstrating low signal in the L3–L4 disk and adjacent vertebral bodies with
destruction of the superior endplate of L3 and inferior endplate of L4. (b) T1-weighted post-gadolinium image showing enhancement of the L3 and L4 vertebral bodies and the
anterior paraspinal soft tissue. (c) T2-weighted image demonstrating increased signal intensity in the L3–L4 disk and the L3 and L4 vertebral bodies.
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pain decreased after rest andwith the administration of analgesics.
The cellulitis improved with prolonged prescription of pristina-
mycin for a total duration of two weeks. Laboratory tests
demonstrated a decrease in inﬂammatory reactants (CRP of
27 mg/l, ESR of 42 mm/h). The patient was discharged to local
care two weeks after his admission.
Three days later, he was readmitted for progressive lower back
pain. Magnetic resonance imaging (MRI) of the dorsolumbar rachis
showed typical septic spondylodiscitis at L3–L4 (Figure 1). A
needle biopsy of the vertebral disk was performed under sterile
conditions using CT guidance. The aspirated material was sent for
microbiological analysis. Microscopic examination of direct Gram-
stained smears revealed polynuclear cells and a few Gram-
negative rods. Samples of the aspirated material were inoculated
onto a chocolate agar plate (BioMe´rieux) incubated at 37 8C in a 5%
CO2 atmosphere and onto 5% sheep blood agar plates (BioMe´rieux)
incubated at 37 8C under aerobic and anaerobic conditions. A
brain–heart infusion broth (Oxoid, Basingstoke, Hampshire, UK)
was inoculated and incubated at 37 8C. Fungal and mycobacterial
cultures were performed. After 48 h, pure culture of a few large
mucoid colonies with a salmon-pink color was observed on the
chocolate agar plate incubated under CO2 atmosphere and on the
sheep blood agar plate incubated under aerobic conditions.
Bacteria were isolated from the brain–heart infusion broth.
Colonies exhibited b-hemolysis on sheep blood agar. No growth
was observed on the sheep blood agar plate incubated in an
anaerobic atmosphere. Oxidase and catalase tests were positive.
Bacteria were motile and Gram-negative.
Biochemical identiﬁcation systems ID32E, ID32GN, and API20E
(BioMe´rieux) identiﬁed the organism as S. putrefaciens with 99%
certainty. However, the b-hemolysis on sheep blood agar, the
growth at 41 8C and not at 4 8C, the growth on nutrient agar
containing 6% NaCl and on Salmonella–Shigella agar, and the
inability to oxidize carbohydrates, suggested that the bacteria
were S. algae.8 The antibiotic susceptibility pattern was deter-
mined by a disk diffusion method (BioRad, Marne la Coquette,
France). The organism was susceptible to amoxicillin, ticarcillin,
piperacillin, aztreonam, cefotaxime, ceftazidime, cefepime, imi-
penem, gentamicin, tobramycin, amikacin, colistin, trimethoprim–sulfamethoxazole, and ciproﬂoxacin and resistant to cephalothin
and fosfomycin according to the criteria of the Comite´ de
l’Antibiogramme de la Socie´te´ Franc¸aise de Microbiologie for
Pseudomonas aeruginosa.9 Fungal and mycobacterial cultures were
negative. For formal identiﬁcation of the bacterial species, the
bacterium was sent to the Institut Pasteur (Paris) for molecular
identiﬁcation by 16S rRNA gene sequencing, where it was
deﬁnitively identiﬁed as S. algae.
The patient was ﬁrst treated intravenously with ceftriaxone
(3 g/day) and amikacin (1.5 g/day) for two weeks, then orally with
ciproﬂoxacin (1.5 g/day) for a total duration of 12weeks. Hewore a
custom-made, thermoformed, resin brace for 12 weeks to
immobilize his lumbar region. His pain abated and laboratory
tests showed no inﬂammation. Three months after completion of
the treatment the patient was well.
3. Discussion
To our knowledge, this is the ﬁrst reported case of human
spondylodiscitis caused by S. algae. It was isolated from a normally
sterile site in pure culture. The skin defect of the leg exposed to
seawater may have been the portal of entry and the vertebral disk
was probably infected after an asymptomatic bacteremia.
S. algae and S. putrefaciens are rarely recovered from human
specimens. They are usually linked to contact with seawater in
countries with a warm climate or during the summer in temperate
countries. Their isolation is usually indicative of colonization. They
are often isolated as part of a mixed bacterial ﬂora.10–12 Their
pathogenic role has been established in only a limited number of
cases.
Commercial automated identiﬁcation systems could not
distinguish S. algae from S. putrefaciens because the chemical
reactions used thus far fail to discriminate between these two
species. Consequently, most isolates reported as S. putrefaciens
might in fact belong to the species S. algae.6,8,11,13 S. algae is the
predominant human pathogen and an experimental study onmice
has shown that it is more virulent than S. putrefaciens.14
Shewanella spp are associated with a broad range of infections
in both patients with underlying diseases and in healthy patients.
Fulminating disease is described in patients with severe underly-
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most common clinical syndrome reported in the literature is
infection of the skin and the soft tissues.10,17 It often happens in
elderly patients with chronic ulcers of the lower extremities, but
soft tissue infections in healthy subjects have also been
described.18,19 Bacteremia is often present, but its evolution is
usually benign. Only a few patients will develop necrotizing
fasciitis.20–22 In Denmark the most common clinical syndrome is
acute otitis media, which is mostly found in children after contact
with seawater during particularly hot summers.8 A cerebellar
abscess following otitis media has been reported.23 In a few
patients Shewanella sp has been documented as a pathogen causing
intra-abdominal infections,24 lower respiratory tract infections,12
meningitis,25 and abscesses.26 Severe disease with bacteremia has
been described in patients with predisposing factors such as
immunodeﬁciency,27 malignancy,10,20 hepato-biliary disease,10,22
and renal failure.11,21,28,29
Only two cases of arthritis29,30 and two cases of osteomyeli-
tis31,32 have been reported (Table 1).
Our case was a spondylodiscitis in a patient without any
predisposing underlying disease. The source of infection was likely
a cutaneous leg lesion, following trauma in a marine environment.
The bacterium was isolated in pure culture, and automated
identiﬁcation systems identiﬁed it as S. putrefaciens, but a few
phenotypic criteria were in favor of S. algae. This presumptive
identiﬁcation was conﬁrmed by molecular biology. The outcome
under prolonged treatment was favorable.
In summary, the clinical, radiological, and biological character-
istics of S. algae spondylodiscitis were indistinguishable from those
of spondylodiscitis caused by the usual organisms. We report here
the ﬁrst case of spondylodiscitis due to S. algae and this case is
signiﬁcant in two aspects. Firstly, it highlights the need for
molecular typing of Shewanella spp to obtain a precise identiﬁca-
tion of the bacterium. Secondly, it raises the possibility that S. algae
is a causative pathogen of spondylodiscitis; this is especially true in
patients with cutaneous lesions andwater exposure, because it is a
potential portal of entry for the pathogen.
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